Edap Tms (NASDAQ:EDAP) Stock Price Passes Above 200 Day Moving Average – Here’s Why

Edap Tms S.A. (NASDAQ:EDAP)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.49 and traded as high as $4.20. Edap Tms shares last traded at $4.00, with a volume of 35,373 shares.

Wall Street Analyst Weigh In

EDAP has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. Jefferies Financial Group restated a “hold” rating and issued a $2.00 price target on shares of Edap Tms in a research report on Thursday, November 6th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $8.50.

Edap Tms Stock Performance

The stock has a fifty day simple moving average of $3.36 and a two-hundred day simple moving average of $2.49. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.97 and a current ratio of 1.41. The stock has a market cap of $149.56 million, a price-to-earnings ratio of -7.02 and a beta of -0.16.

Edap Tms (NASDAQ:EDAP) last posted its quarterly earnings results on Thursday, November 6th. The medical equipment provider reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.11. The company had revenue of $16.29 million during the quarter, compared to analysts’ expectations of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. Analysts expect that Edap Tms S.A. will post -0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Sage Mountain Advisors LLC bought a new position in Edap Tms in the 2nd quarter valued at approximately $165,000. Simplicity Wealth LLC bought a new stake in shares of Edap Tms during the second quarter worth $54,000. Finally, Financial Planning Navigators CORP acquired a new position in shares of Edap Tms during the fourth quarter worth $33,000. 62.74% of the stock is owned by institutional investors.

Edap Tms Company Profile

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.